Elevance Health, Inc. (ELV) Guidance & Earnings Results
On 2026-10-21 Elevance Health, Inc. raised guidance: "FY2026 adjusted diluted EPS guidance raised to at least $29.00; FY2026 diluted EPS guidance raised to at least $22.00; FY2026 operating cash flow guidance raised to at least…" — from its own filing, as read by EquiReason.
Source: SEC EDGAR filings · figures as of 2026-09-30 · read by EquiReason
ELVElevance Health, Inc.Follow ELV — free
—
Price chart with a free account
- Market cap
- 95.1B
- P/E TTM
- 18.7
- Dividend yield
- 1.6%
- 52-week
- —
- Next earnings
- 26 Jan, in 94 days
What management guided
each earnings 8-K · figures checked against the filing text| Release | Direction | What they said |
|---|---|---|
| 21 Oct 26 | Raised | FY2026 adjusted diluted EPS guidance raised to at least $29.00; FY2026 diluted EPS guidance raised to at least $22.00; FY2026 operating cash flow guidance raised to at least $6.5B · full year |
| 15 Jul 26 | Raised | FY26 adjusted diluted EPS guidance raised to at least $27.00; FY26 diluted EPS guidance raised to at least $20.10; FY26 operating cash flow guidance raised to at least $6.0 billion · full year |
| 28 Jan 26 | Lowered | FY2026 adjusted EPS guidance at least $25.50 vs FY2025 $30.29, implying ~16% decline. · full year |
| 21 Oct 25 | Reaffirmed | Adjusted EPS ~$30.00, benefit expense ratio ~90.0% · full year |
Elevance Health, Inc. — questions
- What guidance did Elevance Health, Inc. give?
- On 2026-10-21: "FY2026 adjusted diluted EPS guidance raised to at least $29.00; FY2026 diluted EPS guidance raised to at least $22.00; FY2026 operating cash flow guidance raised to at least $6.5B"
- When does Elevance Health, Inc. report earnings?
- Elevance Health, Inc.'s next earnings report is expected on 2027-01-26.
Every figure on this page comes from Elevance Health, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.